Advisors Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Advisors Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,359	Closed	-$146K	–	1838
2016 Q4	$146K	Sell	1,359 -59	-4%	-$6.9K	﹤0.01%	1433
2016 Q3	$177K	Sell	1,418 -2,738	-66%	-$323K	﹤0.01%	1377
2016 Q2	$442K	Sell	4,156 -112	-3%	-$13K	0.01%	1148
2016 Q1	$489K	Sell	4,268 -329	-7%	-$38.6K	0.01%	1091
2015 Q4	$655K	Sell	4,597 -225	-5%	-$26K	0.01%	1042
2015 Q3	$433K	Sell	4,822 -1	-0%	-$106	0.01%	1125
2015 Q2	$555K	Buy	4,823 +652	+16%	+$68.5K	0.01%	1089
2015 Q1	$398K	Buy	4,171 +636	+18%	+$47.6K	0.01%	1164
2014 Q4	$238K	Buy	3,535 +1,041	+42%	+$64.5K	﹤0.01%	1275
2014 Q3	$135K	Buy	+2,494	New	+$123K	﹤0.01%	1372

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Advisors Asset Management's CBPO Position: Q1 2017 in Review

Advisors Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2017, closing a stake of 1,359 shares — an estimated $146K sold.

Advisors Asset Management first reported a position in CBPO in Q3 2014 and held it in 10 quarters. The position peaked at $655K in Q4 2015. 137 funds tracked by Wall St. Rank hold CBPO as of Q1 2017.

Advisors Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Advisors Asset Management sold 1,359 China Biologic Products Holdings, Inc. shares in Q1 2017, an estimated $146K.
Advisors Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2014 and held it in 10 quarters.
Advisors Asset Management's China Biologic Products Holdings, Inc. position peaked at $655K in Q4 2015.
137 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2017.

Based on Advisors Asset Management's 13F filing for Q1 2017, filed 2 May 2017.